Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CornerLoc vs SI Joint Steroid Injection
NCT04218838Terminated
- Sponsor
- CornerLoc
- Start
- Aug 2020
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in sacroiliac joint dysfunction (2 arms), sponsored by CornerLoc. Primary endpoint: Efficacy responder rate at 6 months. Started Aug 2020; status: terminated.
02
Conditions
sacroiliac joint dysfunction
Beyond the preview
Go deeper on NCT04218838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218838.